Literature DB >> 6693430

Immunological probe of estrogen biosynthesis. Evidence for the 2 beta-hydroxylative pathway in aromatization of androgens.

E F Hahn, J Fishman.   

Abstract

The terminal hydroxylation in placental estrogen biosynthesis from androgens is at the 2 beta position. The 2 beta-hydroxy-19-oxoandrogen derivative collapses nonenzymatically to estrogen and is therefore the proximate precursor of the female hormone. To establish the role of this pathway in biological aromatization, an immunological approach was employed in which an antibody was obtained which recognizes 2 beta-hydroxy-19-oxygenated androgens but not intermediates oxygenated at C-19 only. Binding of the 2 beta-hydroxy-19-oxo intermediate by the antibody stabilizes it so that its nonenzymatic transformation to estrogen is delayed and results in slower estrogen formation. When placental microsomes were incubated with [1,2-3H]androstenedione in the presence of the antibody antiserum, a 50% decrease in [3H]estradiol formation and 3H2O release was observed when compared with identical incubations containing normal rabbit serum alone. This inhibition is blocked when the antibody is inactivated by presaturation with 2 beta, 19-dihydroxyandrostenedione. Precipitation of immunoglobulins from the incubations followed by heating liberated the 2 beta-hydroxy-19-oxo intermediate (30%) from the antibody, and resulted in its nonenzymatic collapse to estrogen with concomitant release of 3H2O. Control normal rabbit serum or blocked antibody incubations did not show a similar increase in [3H]estradiol or 3H2O yields in the precipitate. Heat treatment (90 degrees C) of the antibody but not normal rabbit serum incubations resulted in a similar increase in [3H]estradiol and 3H2O yields. These results are consistent with the hypothesis that the final and rate-determining hydroxylation in aromatization of androgens is at the 2 beta position and that this pathway is the dominant, if not the sole, route of estrogen biosynthesis by placental aromatase. The antibody probe also permits the characterization of aromatization mechanisms in tissues other than the placenta.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693430

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Formation and Cleavage of C-C Bonds by Enzymatic Oxidation-Reduction Reactions.

Authors:  F Peter Guengerich; Francis K Yoshimoto
Journal:  Chem Rev       Date:  2018-06-22       Impact factor: 60.622

Review 2.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

3.  19-Hydroxylation of androgens in the rat brain.

Authors:  E F Hahn; S Miyairi; J Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

Review 4.  Aromatase, estrone sulfatase, and 17β-hydroxysteroid dehydrogenase: structure-function studies and inhibitor development.

Authors:  Yanyan Hong; Shiuan Chen
Journal:  Mol Cell Endocrinol       Date:  2010-10-01       Impact factor: 4.102

Review 5.  Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.

Authors:  V Craig Jordan; Angela M H Brodie
Journal:  Steroids       Date:  2006-12-13       Impact factor: 2.668

6.  Conversion of 19-oxo[2 beta-2H]androgens into oestrogens by human placental aromatase. An unexpected stereochemical outcome.

Authors:  P A Cole; C H Robinson
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

7.  Mechanism of 17α,20-Lyase and New Hydroxylation Reactions of Human Cytochrome P450 17A1: 18O LABELING AND OXYGEN SURROGATE EVIDENCE FOR A ROLE OF A PERFERRYL OXYGEN.

Authors:  Francis K Yoshimoto; Eric Gonzalez; Richard J Auchus; F Peter Guengerich
Journal:  J Biol Chem       Date:  2016-06-23       Impact factor: 5.157

8.  Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors.

Authors:  Liewei Wang; Katarzyna A Ellsworth; Irene Moon; Linda L Pelleymounter; Bruce W Eckloff; Yvette N Martin; Brooke L Fridley; Gregory D Jenkins; Anthony Batzler; Vera J Suman; Saranya Ravi; J Michael Dixon; William R Miller; Eric D Wieben; Aman Buzdar; Richard M Weinshilboum; James N Ingle
Journal:  Cancer Res       Date:  2010-01-01       Impact factor: 12.701

9.  Mechanism of the third oxidative step in the conversion of androgens to estrogens by cytochrome P450 19A1 steroid aromatase.

Authors:  Francis K Yoshimoto; F Peter Guengerich
Journal:  J Am Chem Soc       Date:  2014-10-10       Impact factor: 15.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.